5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one

C169H227BBrN23O18 — CID 157116123

IUPAC5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one
SMILESCC1(C)OB(C2=CCCCC2)OC1(C)C.CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c1C.CCN(CC)CCNC(=O)c1c(C)[nH]c(C=O)c1C.Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c(C)c1C(=O)N1CCN(C)CC1.Cc1[nH]c(C=O)c(C)c1C(=O)N1CCN(C)CC1.O=C1Cc2cc(Br)ccc2N1.O=C1Cc2cc(C3=CCCCC3)ccc2N1.O=C1Cc2cc(C3CCCCC3)ccc2N1.O=C1Cc2cc(C3CCN(C4CCOCC4)CC3)ccc2N1.O=C1Cc2cc(C3CCNCC3)ccc2N1
InChIInChI=1S/C32H45N5O3.C31H41N5O3.C18H24N2O2.C14H23N3O2.C14H17NO.C14H15NO.C13H19N3O2.C13H16N2O.C12H21BO2.C8H6BrNO/c1-5-36(6-2)16-13-33-32(39)30-21(3)29(34-22(30)4)20-27-26-19-24(7-8-28(26)35-31(27)38)23-9-14-37(15-10-23)25-11-17-40-18-12-25;1-20-28(32-21(2)29(20)31(38)36-14-12-34(3)13-15-36)19-26-25-18-23(4-5-27(25)33-30(26)37)22-6-10-35(11-7-22)24-8-16-39-17-9-24;21-18-12-15-11-14(1-2-17(15)19-18)13-3-7-20(8-4-13)16-5-9-22-10-6-16;1-5-17(6-2)8-7-15-14(19)13-10(3)12(9-18)16-11(13)4;2*16-14-9-12-8-11(6-7-13(12)15-14)10-4-2-1-3-5-10;1-9-11(8-17)14-10(2)12(9)13(18)16-6-4-15(3)5-7-16;16-13-8-11-7-10(1-2-12(11)15-13)9-3-5-14-6-4-9;1-11(2)12(3,4)15-13(14-11)10-8-6-5-7-9-10;9-6-1-2-7-5(3-6)4-8(11)10-7/h7-8,19-20,23,25,34H,5-6,9-18H2,1-4H3,(H,33,39)(H,35,38);4-5,18-19,22,24,32H,6-17H2,1-3H3,(H,33,37);1-2,11,13,16H,3-10,12H2,(H,19,21);9,16H,5-8H2,1-4H3,(H,15,19);6-8,10H,1-5,9H2,(H,15,16);4,6-8H,1-3,5,9H2,(H,15,16);8,14H,4-7H2,1-3H3;1-2,7,9,14H,3-6,8H2,(H,15,16);8H,5-7,9H2,1-4H3;1-3H,4H2,(H,10,11)/b27-20-;26-19-;;;;;;;;
InChIKeyAHKRYRWQNAHEQV-GNJKRDNMSA-N
MW2959.53 g/mol
LogP26.39
Rot. Bonds28

About 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one

5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one (PubChem CID 157116123) has the molecular formula C169H227BBrN23O18 and a molecular weight of 2959.53 g/mol. Its IUPAC name is 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one.

Molecular Properties

Compound Name5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one
PubChem CID157116123
Molecular FormulaC169H227BBrN23O18
Molecular Weight2959.53 g/mol
Exact Mass2956.68
IUPAC Name5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one
SMILESCC1(C)OB(C2=CCCCC2)OC1(C)C.CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c1C.CCN(CC)CCNC(=O)c1c(C)[nH]c(C=O)c1C.Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c(C)c1C(=O)N1CCN(C)CC1.Cc1[nH]c(C=O)c(C)c1C(=O)N1CCN(C)CC1.O=C1Cc2cc(Br)ccc2N1.O=C1Cc2cc(C3=CCCCC3)ccc2N1.O=C1Cc2cc(C3CCCCC3)ccc2N1.O=C1Cc2cc(C3CCN(C4CCOCC4)CC3)ccc2N1.O=C1Cc2cc(C3CCNCC3)ccc2N1
InChIInChI=1S/C32H45N5O3.C31H41N5O3.C18H24N2O2.C14H23N3O2.C14H17NO.C14H15NO.C13H19N3O2.C13H16N2O.C12H21BO2.C8H6BrNO/c1-5-36(6-2)16-13-33-32(39)30-21(3)29(34-22(30)4)20-27-26-19-24(7-8-28(26)35-31(27)38)23-9-14-37(15-10-23)25-11-17-40-18-12-25;1-20-28(32-21(2)29(20)31(38)36-14-12-34(3)13-15-36)19-26-25-18-23(4-5-27(25)33-30(26)37)22-6-10-35(11-7-22)24-8-16-39-17-9-24;21-18-12-15-11-14(1-2-17(15)19-18)13-3-7-20(8-4-13)16-5-9-22-10-6-16;1-5-17(6-2)8-7-15-14(19)13-10(3)12(9-18)16-11(13)4;2*16-14-9-12-8-11(6-7-13(12)15-14)10-4-2-1-3-5-10;1-9-11(8-17)14-10(2)12(9)13(18)16-6-4-15(3)5-7-16;16-13-8-11-7-10(1-2-12(11)15-13)9-3-5-14-6-4-9;1-11(2)12(3,4)15-13(14-11)10-8-6-5-7-9-10;9-6-1-2-7-5(3-6)4-8(11)10-7/h7-8,19-20,23,25,34H,5-6,9-18H2,1-4H3,(H,33,39)(H,35,38);4-5,18-19,22,24,32H,6-17H2,1-3H3,(H,33,37);1-2,11,13,16H,3-10,12H2,(H,19,21);9,16H,5-8H2,1-4H3,(H,15,19);6-8,10H,1-5,9H2,(H,15,16);4,6-8H,1-3,5,9H2,(H,15,16);8,14H,4-7H2,1-3H3;1-2,7,9,14H,3-6,8H2,(H,15,16);8H,5-7,9H2,1-4H3;1-3H,4H2,(H,10,11)/b27-20-;26-19-;;;;;;;;
InChIKeyAHKRYRWQNAHEQV-GNJKRDNMSA-N
XLogP26.39
TPSA480.68 Ų
H-Bond Donors14
H-Bond Acceptors26
Rotatable Bonds28
Heavy Atoms212
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002959.53
LogP ≤ 526.39
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one?
The IUPAC name of 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one (CID 157116123) is 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one.
What is the SMILES notation for 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one?
The canonical SMILES for 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one is CC1(C)OB(C2=CCCCC2)OC1(C)C.CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c1C.CCN(CC)CCNC(=O)c1c(C)[nH]c(C=O)c1C.Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C4CCN(C5CCOCC5)CC4)cc32)c(C)c1C(=O)N1CCN(C)CC1.Cc1[nH]c(C=O)c(C)c1C(=O)N1CCN(C)CC1.O=C1Cc2cc(Br)ccc2N1.O=C1Cc2cc(C3=CCCCC3)ccc2N1.O=C1Cc2cc(C3CCCCC3)ccc2N1.O=C1Cc2cc(C3CCN(C4CCOCC4)CC3)ccc2N1.O=C1Cc2cc(C3CCNCC3)ccc2N1.
What is the InChIKey of 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one?
The InChIKey is AHKRYRWQNAHEQV-GNJKRDNMSA-N. The full InChI is InChI=1S/C32H45N5O3.C31H41N5O3.C18H24N2O2.C14H23N3O2.C14H17NO.C14H15NO.C13H19N3O2.C13H16N2O.C12H21BO2.C8H6BrNO/c1-5-36(6-2)16-13-33-32(39)30-21(3)29(34-22(30)4)20-27-26-19-24(7-8-28(26)35-31(27)38)23-9-14-37(15-10-23)25-11-17-40-18-12-25;1-20-28(32-21(2)29(20)31(38)36-14-12-34(3)13-15-36)19-26-25-18-23(4-5-27(25)33-30(26)37)22-6-10-35(11-7-22)24-8-16-39-17-9-24;21-18-12-15-11-14(1-2-17(15)19-18)13-3-7-20(8-4-13)16-5-9-22-10-6-16;1-5-17(6-2)8-7-15-14(19)13-10(3)12(9-18)16-11(13)4;2*16-14-9-12-8-11(6-7-13(12)15-14)10-4-2-1-3-5-10;1-9-11(8-17)14-10(2)12(9)13(18)16-6-4-15(3)5-7-16;16-13-8-11-7-10(1-2-12(11)15-13)9-3-5-14-6-4-9;1-11(2)12(3,4)15-13(14-11)10-8-6-5-7-9-10;9-6-1-2-7-5(3-6)4-8(11)10-7/h7-8,19-20,23,25,34H,5-6,9-18H2,1-4H3,(H,33,39)(H,35,38);4-5,18-19,22,24,32H,6-17H2,1-3H3,(H,33,37);1-2,11,13,16H,3-10,12H2,(H,19,21);9,16H,5-8H2,1-4H3,(H,15,19);6-8,10H,1-5,9H2,(H,15,16);4,6-8H,1-3,5,9H2,(H,15,16);8,14H,4-7H2,1-3H3;1-2,7,9,14H,3-6,8H2,(H,15,16);8H,5-7,9H2,1-4H3;1-3H,4H2,(H,10,11)/b27-20-;26-19-;;;;;;;;.
What are the key properties of 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one?
5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one has a molecular weight of 2959.53 g/mol, XLogP of 26.39, 28 rotatable bonds, 14 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-1,3-dihydroindol-2-one;5-(cyclohexen-1-yl)-1,3-dihydroindol-2-one;2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;5-cyclohexyl-1,3-dihydroindol-2-one;N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[5-[1-(oxan-4-yl)piperidin-4-yl]-2-oxo-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide;N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide;3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrole-2-carbaldehyde;(3Z)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-5-[1-(oxan-4-yl)piperidin-4-yl]-1H-indol-2-one;5-[1-(oxan-4-yl)piperidin-4-yl]-1,3-dihydroindol-2-one;5-piperidin-4-yl-1,3-dihydroindol-2-one is sourced from PubChem (CID 157116123), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).